Cost–Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes
Control-IQ provides clinical benefits relative to MDI and standard insulin pump therapy plus CGM in adults with type 1 diabetes in Belgium and appears to be cost-effective in this setting, considering commonly used thresholds. These findings support the broader adoption of automated insulin delivery systems in diabetes management.
Authors
- Gerd Vanhaverbeke (ORCID: https://orcid.org/0000-0001-6986-6695)
- Margaretha M. Visser (ORCID: https://orcid.org/0000-0003-0216-4028)
- Youri Taes
- Katrien Spincemaille
- Jeroen Luyten (ORCID: https://orcid.org/0000-0001-6398-4025)
- Christophe De Block (ORCID: https://orcid.org/0000-0002-0679-3203)
- F Fiorentino (ORCID: https://orcid.org/0000-0003-2092-3593)
- CHRIS F. VERCAMMEN
- Joke Marlier (ORCID: https://orcid.org/0000-0002-9500-608X)
- Liesbeth Van Huffel
- BART KEYMEULEN
- Ine Lowyck
- Vanessa Preumont
- Dominique Ballaux
- Sharon M. Wang
- Jordan E. Pinsker (ORCID: https://orcid.org/0009-0004-7621-5267)
- Chantal Mathieu (ORCID: https://orcid.org/0000-0002-6099-2406)
- Ides M. Colin
- Jolien De Meulemeester
- Nuno Picado
- Bimal V. Patel
- Pieter Gillard
Institutions
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- AZ Groeninge (BE)
- Ghent University Hospital (BE)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Antwerp University Hospital (BE)
- Tandem Diabetes Care (United States) (US)
- AZ Sint-Jan (BE)
- Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE)
- Haute École Louvain en Hainaut (BE)
- Imelda Hospital (BE)
- Escola Secundária Quinta do Marquês (PT)
- AZ Delta (BE)
- Flanders Environment Agency (BE)
- Ziekenhuis Oost-Limburg (BE)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1177/15209156251408041
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00